What are ATR kinase inhibitor drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ATR kinase inhibitor drugs are pharmacologic agents that share a common mechanism (typically targeting ATR). 0 are currently marketed, with 2 more in clinical development.

ATR kinase inhibitor

0 marketed 2 in Phase 1

This page covers all ATR kinase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ATR.

Targets

ATR

Phase 1 pipeline (2)

AZD5363when combined with weekly paclitaxel. · AstraZeneca · Oncology
ATR kinase inhibitor
Administration of AZD6738 · AstraZeneca · Oncology
AZD6738 is a selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase, which plays a critical role in the DNA damage response pathway.

Patent intelligence

atr kinase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates